Literature DB >> 27603509

Evaluation of a simplified modified Atkins diet for use by parents with low levels of literacy in children with refractory epilepsy: A randomized controlled trial.

Suvasini Sharma1, Shaiphali Goel2, Puneet Jain3, Anuja Agarwala4, Satinder Aneja5.   

Abstract

PURPOSE: This study was planned to develop and evaluate a simple, easy-to-understand variation of the modified Atkins diet, for use by parents with low levels of literacy in children with refractory epilepsy.
METHODS: This study was conducted in two phases. In the first phase, a simplified version of the modified Atkins diet was developed. In the second phase this was evaluated in children aged 2-14 years who had daily seizures despite the appropriate use of at least two anticonvulsant drugs, in an open-label randomized-controlled-trial. Children were randomized to receive either the simplified modified Atkins diet or no dietary intervention for a period of 3 months with the ongoing anticonvulsant medications being continued unchanged in both the groups. Reduction in seizure frequency was the primary outcome-measure. Data was analyzed using intention to treat approach. Adverse effects were also studied. (Clinical trial identifier NCT0189989).
RESULTS: Forty-one children were randomly assigned to the diet-group, and 40 were assigned to the control-group. Two patients discontinued the diet during the study period. The proportion of children with>50% seizure reduction was significantly higher in the diet group as compared to the control group (56.1% vs 7.5%, p<0.0001). The proportion of children with 90% seizure reduction was also higher in the diet group (19.5% vs 2%, p=0.09). Six children in the diet group were seizure free at 3 months compared with two in the control group (p=0.26). At 3 months, 6 children had constipation and 5 had weight loss.
CONCLUSION: A simplified version of the modified Atkins diet was developed for use by parents with low levels literacy. This diet was found to be feasible, efficacious and well tolerated in children with refractory epilepsy.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dietary therapies; Ketogenic diet; Seizures

Mesh:

Year:  2016        PMID: 27603509     DOI: 10.1016/j.eplepsyres.2016.09.002

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  12 in total

Review 1.  Intractable Generalized Epilepsy: Therapeutic Approaches.

Authors:  Sean T Hwang; Scott J Stevens; Aradia X Fu; Simona V Proteasa
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-26       Impact factor: 5.081

Review 2.  Ketogenic diet for epilepsy: an overview of systematic review and meta-analysis.

Authors:  Yue Ruan; Lian Chen; Dongli She; Yuehuan Chung; Long Ge; Lin Han
Journal:  Eur J Clin Nutr       Date:  2022-01-13       Impact factor: 4.884

Review 3.  The Therapeutic Role of Ketogenic Diet in Neurological Disorders.

Authors:  Diana Pietrzak; Kamila Kasperek; Paweł Rękawek; Iwona Piątkowska-Chmiel
Journal:  Nutrients       Date:  2022-05-06       Impact factor: 6.706

Review 4.  Dietary Therapies: Emerging Paradigms in Therapy of Drug Resistant Epilepsy in Children : Based on 6th Dr. I. C. Verma Excellence in Research Award Oration.

Authors:  Sheffali Gulati
Journal:  Indian J Pediatr       Date:  2018-09-21       Impact factor: 1.967

5.  Ketogenic diets for drug-resistant epilepsy.

Authors:  Kirsty J Martin-McGill; Cerian F Jackson; Rebecca Bresnahan; Robert G Levy; Paul N Cooper
Journal:  Cochrane Database Syst Rev       Date:  2018-11-07

6.  Ketogenic diets for drug-resistant epilepsy.

Authors:  Kirsty J Martin-McGill; Rebecca Bresnahan; Robert G Levy; Paul N Cooper
Journal:  Cochrane Database Syst Rev       Date:  2020-06-24

7.  Non-ketogenic combination of nutritional strategies provides robust protection against seizures.

Authors:  Glenn Dallérac; Julien Moulard; Jean-François Benoist; Stefan Rouach; Stéphane Auvin; Angèle Guilbot; Loïc Lenoir; Nathalie Rouach
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

8.  Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.

Authors:  Eric H Kossoff; Beth A Zupec-Kania; Stéphane Auvin; Karen R Ballaban-Gil; A G Christina Bergqvist; Robyn Blackford; Jeffrey R Buchhalter; Roberto H Caraballo; J Helen Cross; Maria G Dahlin; Elizabeth J Donner; Orkide Guzel; Rana S Jehle; Joerg Klepper; Hoon-Chul Kang; Danielle A Lambrechts; Y M Christiana Liu; Janak K Nathan; Douglas R Nordli; Heidi H Pfeifer; Jong M Rho; Ingrid E Scheffer; Suvasini Sharma; Carl E Stafstrom; Elizabeth A Thiele; Zahava Turner; Maria M Vaccarezza; Elles J T M van der Louw; Pierangelo Veggiotti; James W Wheless; Elaine C Wirrell
Journal:  Epilepsia Open       Date:  2018-05-21

Review 9.  Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations.

Authors:  Huiyuan Zhu; Dexi Bi; Youhua Zhang; Cheng Kong; Jiahao Du; Xiawei Wu; Qing Wei; Huanlong Qin
Journal:  Signal Transduct Target Ther       Date:  2022-01-17

10.  Commentary: Consumer Reports of "Keto Flu" Associated With the Ketogenic Diet.

Authors:  Miguel Sáenz de Pipaón; Katherine Flores-Rojas; Angel Gil; Mercedes Gil-Campos
Journal:  Front Nutr       Date:  2020-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.